HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Papotti Selected Research

Thyroid Nuclear Factor 1

1/2019Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.
6/2013ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
11/2011Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
6/2011Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Papotti Research Topics

Disease

128Neoplasms (Cancer)
08/2022 - 01/2000
43Carcinoma (Carcinomatosis)
05/2021 - 02/2002
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 10/2006
23Lung Neoplasms (Lung Cancer)
06/2021 - 05/2009
18Adenocarcinoma
02/2021 - 07/2004
17Carcinoid Tumor (Carcinoid)
01/2020 - 06/2005
15Adrenocortical Carcinoma
05/2021 - 12/2006
14Prostatic Neoplasms (Prostate Cancer)
10/2019 - 02/2004
11Neoplasm Metastasis (Metastasis)
02/2017 - 10/2006
10Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2022 - 11/2007
9Mesothelioma
08/2022 - 10/2002
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 07/2004
7Neuroendocrine Carcinoma
09/2022 - 11/2009
7Thyroid Neoplasms (Thyroid Cancer)
12/2020 - 01/2000
6Papillary Carcinoma
01/2022 - 10/2002
6Malignant Mesothelioma
01/2022 - 07/2008
6Adenoma (Adenomas)
05/2021 - 08/2004
6Necrosis
01/2021 - 08/2004
5Adenocarcinoma of Lung
01/2021 - 06/2006
5Small Cell Carcinoma
09/2019 - 02/2010
4Hyperplasia
01/2021 - 02/2004
4Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2017 - 06/2012
4Carcinogenesis
12/2016 - 01/2003
4Disease Progression
03/2016 - 06/2008
4Large Cell Carcinoma
06/2013 - 05/2009
4Parathyroid Neoplasms (Parathyroid Neoplasm)
01/2013 - 03/2002
3Sarcoma (Soft Tissue Sarcoma)
04/2022 - 04/2016
3Lymphatic Metastasis
01/2022 - 09/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 01/2007
3Thyroid Nodule (Nodule, Thyroid)
01/2021 - 02/2003
3Hemangiosarcoma (Angiosarcoma)
01/2021 - 01/2008
3Pleurisy (Pleuritis)
01/2021 - 10/2002
3Cushing Syndrome
11/2019 - 01/2011
3Breast Neoplasms (Breast Cancer)
02/2017 - 01/2009
3Starvation
07/2014 - 02/2007
3Adenosquamous Carcinoma
06/2013 - 06/2011
3Carcinosarcoma
06/2013 - 04/2012
3Inflammation (Inflammations)
08/2012 - 11/2003
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2012 - 06/2008
3Colorectal Neoplasms (Colorectal Cancer)
11/2010 - 03/2007

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2002
21Biomarkers (Surrogate Marker)IBA
06/2022 - 09/2007
18Biological ProductsIBA
01/2021 - 04/2003
17Messenger RNA (mRNA)IBA
11/2019 - 02/2002
12GhrelinIBA
01/2013 - 03/2002
11Thymidylate SynthaseIBA
08/2022 - 10/2006
10ParaffinIBA
05/2021 - 03/2002
9Hormones (Hormone)IBA
09/2021 - 03/2002
9DNA (Deoxyribonucleic Acid)IBA
04/2020 - 09/2004
9Galectin 3 (LGALS3)IBA
06/2008 - 10/2002
8MucinsIBA
01/2019 - 11/2003
8AndrogensIBA
01/2019 - 10/2002
7MicroRNAs (MicroRNA)IBA
08/2022 - 11/2011
7AsbestosIBA
01/2022 - 07/2008
7AntibodiesIBA
11/2019 - 06/2007
7Formaldehyde (Formol)FDA Link
01/2019 - 03/2002
7Chromogranin AIBA
01/2018 - 08/2005
7Mitotane (Lysodren)FDA Link
06/2017 - 06/2007
6Transcription Factors (Transcription Factor)IBA
09/2022 - 02/2002
6ErbB Receptors (EGF Receptor)IBA
04/2022 - 03/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2009
5TOR Serine-Threonine KinasesIBA
06/2018 - 01/2009
5LigandsIBA
01/2018 - 01/2000
5Caveolin 1IBA
02/2017 - 07/2009
5Fluorouracil (Carac)FDA LinkGeneric
04/2012 - 10/2007
4Tyrosine Kinase InhibitorsIBA
04/2022 - 09/2007
4Anaplastic Lymphoma KinaseIBA
04/2022 - 09/2012
4B7-H1 AntigenIBA
01/2021 - 01/2019
4Thyroid Nuclear Factor 1IBA
01/2019 - 06/2011
4Coloring Agents (Dyes)IBA
10/2017 - 06/2007
4Ki-67 Antigen (Ki 67 Antigen)IBA
02/2017 - 03/2014
4Colloids (Colloid)IBA
04/2016 - 08/2004
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 11/2009
4Prostate-Specific Antigen (Semenogelase)IBA
12/2014 - 09/2007
4Ghrelin ReceptorsIBA
01/2007 - 02/2002
3OsteopontinIBA
05/2021 - 07/2008
3prolinedithiocarbamate (PDTC)IBA
12/2020 - 03/2010
3EnzymesIBA
01/2020 - 08/2006
3RNA (Ribonucleic Acid)IBA
12/2019 - 06/2008
3Keratin-7 (Cytokeratin 7)IBA
05/2019 - 06/2009
3Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2019 - 02/2003
3MTOR InhibitorsIBA
06/2018 - 12/2010
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018 - 08/2006
3Cadherins (E-Cadherin)IBA
12/2016 - 09/2010
3Matrix Metalloproteinases (MMPs)IBA
12/2016 - 12/2006
3Cisplatin (Platino)FDA LinkGeneric
06/2015 - 11/2009
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2015 - 06/2012
3Octreotide (Sandostatin)FDA LinkGeneric
03/2014 - 08/2006
3GemcitabineFDA Link
01/2014 - 06/2010
3Reticulin (Reticular Fiber)IBA
09/2013 - 12/2011
3VimentinIBA
04/2012 - 10/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2009 - 10/2002
3Keratins (Keratin)IBA
01/2008 - 11/2003
3SecretagoguesIBA
02/2004 - 02/2002

Therapy/Procedure

34Therapeutics
06/2021 - 08/2006
10Drug Therapy (Chemotherapy)
08/2022 - 10/2007
4Prostatectomy (Retropubic Prostatectomy)
03/2016 - 06/2008
3Immunotherapy
04/2022 - 01/2018
3Neoadjuvant Therapy
01/2020 - 11/2010
3Radiotherapy
10/2015 - 11/2010